Ranolazine Provides Benefit over Placebo for T2DM Patients with Angina

Article Figures & Data

Figures

  • Figure 1.

    Angina Frequency With Ranolazine Versus Placebo

    Reproduced from Kosiborod M et al. Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina. Results from the TERISA randomized clinical trial. Journal of the American College of Cardiology Jan 2013; 10.1016/J.JACC.2013.02.011. With permission from Elsevier.
  • Figure 2.

    Average SL NTG Doses With Ranolazine Versus Placebo

    SL NTG=sublingual nitroglycerin.Reproduced from Kosiborod M et al. Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina. Results from the TERISA randomized clinical trial. Journal of the American College of Cardiology Jan 2013; 10.1016/J.JACC.2013.02.011. With permission from Elsevier.